Global Blood Collection Market Research and Analysis, 2015-2021
MARKET INSIGHTS
The market is expected to grow at a CAGR of 5.3% from 2016-2021, owing to increasing number of patients with chronic diseases that lead to higher number of surgeries. Rising cases of accidents are also responsible for growth of blood collection market. However, risks of acquiring infections due to unhygienic blood transfusion process and stringent regulatory scenario are expected to dampen market growth during the forecasted period. Implementation of innovative techniques such as RFID in blood transfusion and storage processes present great opportunities for the market to grow during the forecasted period.
North America dominates the market due to increasing incidences of contagious diseases and lifestyle induced diseases. Sophisticated healthcare infrastructure and rapid adoption of advanced technologies are some of the major factors fuelling market growth in this region. However, APAC is expected to be the fastest growing market owing to increasing rate of disease prevalence that leads to rise in blood inventory management. Economic development of countries such as China, India, Japan and South Korea also contribute in rising healthcare expenditure, thus boosting the market.
The key players in the global Blood Collection market profiled in this report include Becton, Dickinson and Company, Abbott Laboratories, Nipro Medical Corporation, Terumo Corporation,
Argon, Covidien, Cr Bard, Ecolab, FL Medical, Greiner Holding Ag, Haemonetics Corporation, Medtronic, Qiagen and Sarstedt Ag & Co.
The market is segmented by product, applications, end users and geography. The market segmentation on the basis of product include blood collection needles and syringes, blood collection tubes, blood lancets, blood bags, vials, and other blood collection equipments. On the basis of applications, the market is segregated into infectious and non infectious diseases diagnostics. Segmentation on the basis of end users include hospitals, diagnostic centers and laboratories, blood banks and others. The market is segmented on the basis of geography which includes North America, Europe, APAC and RoW.
OMR report covers:
The market is expected to grow at a CAGR of 5.3% from 2016-2021, owing to increasing number of patients with chronic diseases that lead to higher number of surgeries. Rising cases of accidents are also responsible for growth of blood collection market. However, risks of acquiring infections due to unhygienic blood transfusion process and stringent regulatory scenario are expected to dampen market growth during the forecasted period. Implementation of innovative techniques such as RFID in blood transfusion and storage processes present great opportunities for the market to grow during the forecasted period.
North America dominates the market due to increasing incidences of contagious diseases and lifestyle induced diseases. Sophisticated healthcare infrastructure and rapid adoption of advanced technologies are some of the major factors fuelling market growth in this region. However, APAC is expected to be the fastest growing market owing to increasing rate of disease prevalence that leads to rise in blood inventory management. Economic development of countries such as China, India, Japan and South Korea also contribute in rising healthcare expenditure, thus boosting the market.
The key players in the global Blood Collection market profiled in this report include Becton, Dickinson and Company, Abbott Laboratories, Nipro Medical Corporation, Terumo Corporation,
Argon, Covidien, Cr Bard, Ecolab, FL Medical, Greiner Holding Ag, Haemonetics Corporation, Medtronic, Qiagen and Sarstedt Ag & Co.
The market is segmented by product, applications, end users and geography. The market segmentation on the basis of product include blood collection needles and syringes, blood collection tubes, blood lancets, blood bags, vials, and other blood collection equipments. On the basis of applications, the market is segregated into infectious and non infectious diseases diagnostics. Segmentation on the basis of end users include hospitals, diagnostic centers and laboratories, blood banks and others. The market is segmented on the basis of geography which includes North America, Europe, APAC and RoW.
OMR report covers:
- Comprehensive research methodology of global Blood collection market.
- In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global Blood collection market.
- Insights about market determinants which are stimulating the global Blood collection market.
- Detailed and extensive market segments with regional distribution of forecasted revenues
- Extensive profiles and recent developments of market players
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PIPELINE ANALYSIS
2.6. ANALYST INSIGHT
2.6.1. KEY FINDINGS
2.6.2. RECOMMENDATION
2.6.3. CONCLUSION
2.7. REGULATIONS
3. MARKET DETERMINANTS
3.1. MOTIVATORS
3.1.1. INCREASING NUMBER OF SURGERIES WORLDWIDE
3.1.2. RISE IN NUMBER OF ACCIDENTS
3.1.3. INCREASING INCIDENCES OF CHRONIC DISEASES REQUIRING SURGICAL TREATMENTS
3.1.4. GOVERNMENT INITIATIVE TO SET OF BLOOD BANKS
3.1.5. AWARENESS TOWARDS BLOOD DONATION
3.1.6. VARIOUS BLOOD DONATION CAMPAIGN ORGANIZED BY GOVERNMENTS AND NGOS
3.2. RESTRAINT
3.2.1. RISKS OF ACQUIRING DISEASES DURING BLOOD TRANSFUSIONS
3.2.2. STRINGENT REGULATORY SCENARIO
3.3. OPPORTUNITY
3.3.1. NEEDLE FREE DEVICES
3.3.2. INNOVATIONS IN TRANSFUSION PROCESSES SUCH AS USE OF RFID
4. MARKET SEGMENTATION
4.1. GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY PRODUCT
4.1.1. NEEDLES AND SYRINGES MARKET RESEARCH AND ANALYSIS
4.1.2. BLOOD COLLECTION TUBES MARKET RESEARCH AND ANALYSIS
4.1.3. BLOOD BAGS MARKET RESEARCH AND ANALYSIS
4.1.4. BLOOD LANCETS MARKET RESEARCH AND ANALYSIS
4.1.5. VIALS MARKET RESEARCH AND ANALYSIS
4.1.6. OTHER MARKET
4.2. GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY APPLICATIONS
4.2.1. INFECTIOUS DISEASES DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS
4.2.2. NON-INFECTIOUS DISEASE DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS
4.2.3. OTHER MARKET
4.3. GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY END-USERS
4.3.1. HOSPITALS MARKET RESEARCH AND ANALYSIS
4.3.2. DIAGNOSTIC CENTERS AND LABORATORIES MARKET RESEARCH AND ANALYSIS
4.3.3. BLOOD BANKS MARKET RESEARCH AND ANALYSIS
4.3.4. OTHER MARKET RESEARCH AND ANALYSIS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS
6.2.2. ROE MARKET RESEARCH AND ANALYSIS
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. PIPELINE ANALYSIS
2.6. ANALYST INSIGHT
2.6.1. KEY FINDINGS
2.6.2. RECOMMENDATION
2.6.3. CONCLUSION
2.7. REGULATIONS
3. MARKET DETERMINANTS
3.1. MOTIVATORS
3.1.1. INCREASING NUMBER OF SURGERIES WORLDWIDE
3.1.2. RISE IN NUMBER OF ACCIDENTS
3.1.3. INCREASING INCIDENCES OF CHRONIC DISEASES REQUIRING SURGICAL TREATMENTS
3.1.4. GOVERNMENT INITIATIVE TO SET OF BLOOD BANKS
3.1.5. AWARENESS TOWARDS BLOOD DONATION
3.1.6. VARIOUS BLOOD DONATION CAMPAIGN ORGANIZED BY GOVERNMENTS AND NGOS
3.2. RESTRAINT
3.2.1. RISKS OF ACQUIRING DISEASES DURING BLOOD TRANSFUSIONS
3.2.2. STRINGENT REGULATORY SCENARIO
3.3. OPPORTUNITY
3.3.1. NEEDLE FREE DEVICES
3.3.2. INNOVATIONS IN TRANSFUSION PROCESSES SUCH AS USE OF RFID
4. MARKET SEGMENTATION
4.1. GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY PRODUCT
4.1.1. NEEDLES AND SYRINGES MARKET RESEARCH AND ANALYSIS
4.1.2. BLOOD COLLECTION TUBES MARKET RESEARCH AND ANALYSIS
4.1.3. BLOOD BAGS MARKET RESEARCH AND ANALYSIS
4.1.4. BLOOD LANCETS MARKET RESEARCH AND ANALYSIS
4.1.5. VIALS MARKET RESEARCH AND ANALYSIS
4.1.6. OTHER MARKET
4.2. GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY APPLICATIONS
4.2.1. INFECTIOUS DISEASES DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS
4.2.2. NON-INFECTIOUS DISEASE DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS
4.2.3. OTHER MARKET
4.3. GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY END-USERS
4.3.1. HOSPITALS MARKET RESEARCH AND ANALYSIS
4.3.2. DIAGNOSTIC CENTERS AND LABORATORIES MARKET RESEARCH AND ANALYSIS
4.3.3. BLOOD BANKS MARKET RESEARCH AND ANALYSIS
4.3.4. OTHER MARKET RESEARCH AND ANALYSIS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS
6.2. EUROPEAN MARKET RESEARCH AND ANALYSIS
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS
6.2.2. ROE MARKET RESEARCH AND ANALYSIS
6.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS
6.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS
LIST OF TABLES
TABLE # 1 GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY PRODUCT 2015 – 2021 ($ MILLION)
TABLE # 2 GLOBAL BLOOD COLLECTION NEEDLES AND SYRINGES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 3 GLOBAL BLOOD COLLECTION TUBES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 4 GLOBAL EDTA MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 5 GLOBAL HEPARIN TUBES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 6 GLOBAL PLASMA SEPARATING TUBE MARKET RESEARCH AND ANALYSIS, 2015-2021($ MILLION)
TABLE # 7 GLOBAL SERUM SEPARATING RUBE MARKET RESEARCH AND ANALYSIS, 2015-2021($ MILLION)
TABLE # 8 GLOBAL BLOOD BAGS MARKET RESEARCH AND ANALYSIS, 2015-2021($ MILLION)
TABLE # 9 GLOBAL BLOOD LANCETS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 10 GLOBAL VIALS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 11 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 12 GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY APPLICATIONS 2015 – 2021 ($ MILLION)
TABLE # 13 GLOBAL INFECTIOUS DISEASES DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 14 GLOBAL NON-INFECTIOUS DISEASE DIAGNOSTICS AND TREATMENT MARKET MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 15 GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY END-USERS 2015 – 2021 ($ MILLION)
TABLE # 16 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 17 GLOBAL DIAGNOSTIC CENTERS AND LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 18 GLOBAL BLOOD BANKS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 19 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 20 ABBOTT LABORATORIES INC. PRODUCT PORTFOLIO
TABLE # 21 ABBOTT LABORATORIES INC. RECENT ACTIVITIES
TABLE # 22 ABBOTT LABORATORIES INC. SWOT ANALYSIS
TABLE # 23 ADVACARE PHARMACEUTICALS PRODUCT PORTFOLIO
TABLE # 24 ADVACARE PHARMACEUTICALS RECENT ACTIVITIES
TABLE # 25 ADVACARE PHARMACEUTICALS SWOT ANALYSIS
TABLE # 26 ARGON PRODUCT PORTFOLIO
TABLE # 27 ARGON RECENT ACTIVITIES
TABLE # 28 ARGON SWOT ANALYSIS
TABLE # 29 BECKMAN COULTER, INC.PRODUCT PORTFOLIO
TABLE # 30 BECKMAN COULTER, INC.RECENT ACTIVITIES
TABLE # 31 BECKMAN COULTER, INC.SWOT ANALYSIS
TABLE # 32 BECTON DICKINSON AND COMPANY PRODUCT PORTFOLIO
TABLE # 33 BECTON DICKINSON AND COMPANY RECENT ACTIVITIES
TABLE # 34 BECTON DICKINSON AND COMPANY SWOT ANALYSIS
TABLE # 35 COVIDIEN PRODUCT PORTFOLIO
TABLE # 36 COVIDIEN RECENT ACTIVITIES
TABLE # 37 COVIDIEN SWOT ANALYSIS
TABLE # 38 CR BARD PRODUCT PORTFOLIO
TABLE # 39 CR BARD RECENT ACTIVITIES
TABLE # 40 CR BARD SWOT ANALYSIS
TABLE # 41 ECOLAB PRODUCT PORTFOLIO
TABLE # 42 ECOLAB RECENT ACTIVITIES
TABLE # 43 ECOLAB SWOT ANALYSIS
TABLE # 44 FL MEDICAL PRODUCT PORTFOLIO
TABLE # 45 FL MEDICAL RECENT ACTIVITIES
TABLE # 46 FL MEDICAL SWOT ANALYSIS
TABLE # 47 FRESENIUS KABI AGPRODUCT PORTFOLIO
TABLE # 48 FRESENIUS KABI AGRECENT ACTIVITIES
TABLE # 49 FRESENIUS KABI AGSWOT ANALYSIS
TABLE # 50 GREINER HOLDING AG PRODUCT PORTFOLIO
TABLE # 51 GREINER HOLDING AG RECENT ACTIVITIES
TABLE # 52 GREINER HOLDING AG SWOT ANALYSIS
TABLE # 53 GRIFOLS INTERNATIONAL S.APRODUCT PORTFOLIO
TABLE # 54 GRIFOLS INTERNATIONAL S.ARECENT ACTIVITIES
TABLE # 55 GRIFOLS INTERNATIONAL S.ASWOT ANALYSIS
TABLE # 56 HAEMONETICS CORPORATION PRODUCT PORTFOLIO
TABLE # 57 HAEMONETICS CORPORATION RECENT ACTIVITIES
TABLE # 58 HAEMONETICS CORPORATION SWOT ANALYSIS
TABLE # 59 IMMUCOR, INC. PRODUCT PORTFOLIO
TABLE # 60 IMMUCOR, INC. RECENT ACTIVITIES
TABLE # 61 IMMUCOR, INC. SWOT ANALYSIS
TABLE # 62 JMS CO. LTD PRODUCT PORTFOLIO
TABLE # 63 JMS CO. LTD RECENT ACTIVITIES
TABLE # 64 JMS CO. LTD SWOT ANALYSIS
TABLE # 65 MEDTRONIC PRODUCT PORTFOLIO
TABLE # 66 MEDTRONIC RECENT ACTIVITIES
TABLE # 67 MEDTRONIC SWOT ANALYSIS
TABLE # 68 NIPRO MEDICAL CORPORATION PRODUCT PORTFOLIO
TABLE # 69 NIPRO MEDICAL CORPORATION RECENT ACTIVITIES
TABLE # 70 NIPRO MEDICAL CORPORATION SWOT ANALYSIS
TABLE # 71 QIAGEN PRODUCT PORTFOLIO
TABLE # 72 QIAGEN RECENT ACTIVITIES
TABLE # 73 QIAGEN SWOT ANALYSIS
TABLE # 74 SARSTEDT AG & CO. PRODUCT PORTFOLIO
TABLE # 75 SARSTEDT AG & CO. RECENT ACTIVITIES
TABLE # 76 SARSTEDT AG & CO. SWOT ANALYSIS
TABLE # 77 TERUMO CORPORATION PRODUCT PORTFOLIO
TABLE # 78 TERUMO CORPORATION RECENT ACTIVITIES
TABLE # 79 TERUMO CORPORATION SWOT ANALYSIS
TABLE # 1 GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY PRODUCT 2015 – 2021 ($ MILLION)
TABLE # 2 GLOBAL BLOOD COLLECTION NEEDLES AND SYRINGES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 3 GLOBAL BLOOD COLLECTION TUBES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 4 GLOBAL EDTA MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 5 GLOBAL HEPARIN TUBES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 6 GLOBAL PLASMA SEPARATING TUBE MARKET RESEARCH AND ANALYSIS, 2015-2021($ MILLION)
TABLE # 7 GLOBAL SERUM SEPARATING RUBE MARKET RESEARCH AND ANALYSIS, 2015-2021($ MILLION)
TABLE # 8 GLOBAL BLOOD BAGS MARKET RESEARCH AND ANALYSIS, 2015-2021($ MILLION)
TABLE # 9 GLOBAL BLOOD LANCETS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 10 GLOBAL VIALS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 11 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 12 GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY APPLICATIONS 2015 – 2021 ($ MILLION)
TABLE # 13 GLOBAL INFECTIOUS DISEASES DIAGNOSTICS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 14 GLOBAL NON-INFECTIOUS DISEASE DIAGNOSTICS AND TREATMENT MARKET MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 15 GLOBAL BLOOD COLLECTION MARKET RESEARCH AND ANALYSIS, BY END-USERS 2015 – 2021 ($ MILLION)
TABLE # 16 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 17 GLOBAL DIAGNOSTIC CENTERS AND LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 18 GLOBAL BLOOD BANKS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 19 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021 ($ MILLION)
TABLE # 20 ABBOTT LABORATORIES INC. PRODUCT PORTFOLIO
TABLE # 21 ABBOTT LABORATORIES INC. RECENT ACTIVITIES
TABLE # 22 ABBOTT LABORATORIES INC. SWOT ANALYSIS
TABLE # 23 ADVACARE PHARMACEUTICALS PRODUCT PORTFOLIO
TABLE # 24 ADVACARE PHARMACEUTICALS RECENT ACTIVITIES
TABLE # 25 ADVACARE PHARMACEUTICALS SWOT ANALYSIS
TABLE # 26 ARGON PRODUCT PORTFOLIO
TABLE # 27 ARGON RECENT ACTIVITIES
TABLE # 28 ARGON SWOT ANALYSIS
TABLE # 29 BECKMAN COULTER, INC.PRODUCT PORTFOLIO
TABLE # 30 BECKMAN COULTER, INC.RECENT ACTIVITIES
TABLE # 31 BECKMAN COULTER, INC.SWOT ANALYSIS
TABLE # 32 BECTON DICKINSON AND COMPANY PRODUCT PORTFOLIO
TABLE # 33 BECTON DICKINSON AND COMPANY RECENT ACTIVITIES
TABLE # 34 BECTON DICKINSON AND COMPANY SWOT ANALYSIS
TABLE # 35 COVIDIEN PRODUCT PORTFOLIO
TABLE # 36 COVIDIEN RECENT ACTIVITIES
TABLE # 37 COVIDIEN SWOT ANALYSIS
TABLE # 38 CR BARD PRODUCT PORTFOLIO
TABLE # 39 CR BARD RECENT ACTIVITIES
TABLE # 40 CR BARD SWOT ANALYSIS
TABLE # 41 ECOLAB PRODUCT PORTFOLIO
TABLE # 42 ECOLAB RECENT ACTIVITIES
TABLE # 43 ECOLAB SWOT ANALYSIS
TABLE # 44 FL MEDICAL PRODUCT PORTFOLIO
TABLE # 45 FL MEDICAL RECENT ACTIVITIES
TABLE # 46 FL MEDICAL SWOT ANALYSIS
TABLE # 47 FRESENIUS KABI AGPRODUCT PORTFOLIO
TABLE # 48 FRESENIUS KABI AGRECENT ACTIVITIES
TABLE # 49 FRESENIUS KABI AGSWOT ANALYSIS
TABLE # 50 GREINER HOLDING AG PRODUCT PORTFOLIO
TABLE # 51 GREINER HOLDING AG RECENT ACTIVITIES
TABLE # 52 GREINER HOLDING AG SWOT ANALYSIS
TABLE # 53 GRIFOLS INTERNATIONAL S.APRODUCT PORTFOLIO
TABLE # 54 GRIFOLS INTERNATIONAL S.ARECENT ACTIVITIES
TABLE # 55 GRIFOLS INTERNATIONAL S.ASWOT ANALYSIS
TABLE # 56 HAEMONETICS CORPORATION PRODUCT PORTFOLIO
TABLE # 57 HAEMONETICS CORPORATION RECENT ACTIVITIES
TABLE # 58 HAEMONETICS CORPORATION SWOT ANALYSIS
TABLE # 59 IMMUCOR, INC. PRODUCT PORTFOLIO
TABLE # 60 IMMUCOR, INC. RECENT ACTIVITIES
TABLE # 61 IMMUCOR, INC. SWOT ANALYSIS
TABLE # 62 JMS CO. LTD PRODUCT PORTFOLIO
TABLE # 63 JMS CO. LTD RECENT ACTIVITIES
TABLE # 64 JMS CO. LTD SWOT ANALYSIS
TABLE # 65 MEDTRONIC PRODUCT PORTFOLIO
TABLE # 66 MEDTRONIC RECENT ACTIVITIES
TABLE # 67 MEDTRONIC SWOT ANALYSIS
TABLE # 68 NIPRO MEDICAL CORPORATION PRODUCT PORTFOLIO
TABLE # 69 NIPRO MEDICAL CORPORATION RECENT ACTIVITIES
TABLE # 70 NIPRO MEDICAL CORPORATION SWOT ANALYSIS
TABLE # 71 QIAGEN PRODUCT PORTFOLIO
TABLE # 72 QIAGEN RECENT ACTIVITIES
TABLE # 73 QIAGEN SWOT ANALYSIS
TABLE # 74 SARSTEDT AG & CO. PRODUCT PORTFOLIO
TABLE # 75 SARSTEDT AG & CO. RECENT ACTIVITIES
TABLE # 76 SARSTEDT AG & CO. SWOT ANALYSIS
TABLE # 77 TERUMO CORPORATION PRODUCT PORTFOLIO
TABLE # 78 TERUMO CORPORATION RECENT ACTIVITIES
TABLE # 79 TERUMO CORPORATION SWOT ANALYSIS
LIST OF FIGURES
FIGURE # 1 GLOBAL BLOOD COLLECTION MARKET BY GEOGRAPHY
FIGURE # 2 GLOBAL APPLICATION MARKET 2015 AND 2021
FIGURE # 3 GLOBAL BLOOD COLLECTION MARKET BY END USER 2015 AND 2021
FIGURE # 4 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 13 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 14 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 15 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES INC.
7.1.1. INTRODUCTION
7.1.2. ABBOTT LABORATORIES INC. PRODUCT PORTFOLIO
7.1.3. ABBOTT LABORATORIES INC. RECENT ACTIVITIES
7.1.4. ABBOTT LABORATORIES INC. SWOT ANALYSIS
7.2. ADVACARE PHARMACEUTICALS
7.2.1. INTRODUCTION
7.2.2. ADVACARE PHARMACEUTICALS PRODUCT PORTFOLIO
7.2.3. ADVACARE PHARMACEUTICALS RECENT ACTIVITIES
7.2.4. ADVACARE PHARMACEUTICALS SWOT ANALYSIS
7.3. ARGON
7.3.1. INTRODUCTION
7.3.2. ARGON PRODUCT PORTFOLIO
7.3.3. ARGON RECENT ACTIVITIES
7.3.4. ARGON SWOT ANALYSIS
7.4. BECKMAN COULTER, INC.
7.4.1. INTRODUCTION
7.4.2. BECKMAN COULTER, INC.PRODUCT PORTFOLIO
7.4.3. BECKMAN COULTER, INC.RECENT ACTIVITIES
7.4.4. BECKMAN COULTER, INC.SWOT ANALYSIS
7.5. BECTON DICKINSON AND COMPANY
7.5.1. INTRODUCTION
7.5.2. BECTON DICKINSON AND COMPANY PRODUCT PORTFOLIO
7.5.3. BECTON DICKINSON AND COMPANY RECENT ACTIVITIES
7.5.4. BECTON DICKINSON AND COMPANY SWOT ANALYSIS
7.6. COVIDIEN
7.6.1. INTRODUCTION
7.6.2. COVIDIEN PRODUCT PORTFOLIO
7.6.3. COVIDIEN RECENT ACTIVITIES
7.6.4. COVIDIEN SWOT ANALYSIS
7.7. CR BARD
7.7.1. INTRODUCTION
7.7.2. CR BARD PRODUCT PORTFOLIO
7.7.3. CR BARD RECENT ACTIVITIES
7.7.4. CR BARD SWOT ANALYSIS
7.8. ECOLAB
7.8.1. INTRODUCTION
7.8.2. ECOLAB PRODUCT PORTFOLIO
7.8.3. ECOLAB RECENT ACTIVITIES
7.8.4. ECOLAB SWOT ANALYSIS
7.9. FL MEDICAL
7.9.1. INTRODUCTION
7.9.2. FL MEDICAL PRODUCT PORTFOLIO
7.9.3. FL MEDICAL RECENT ACTIVITIES
7.9.4. FL MEDICAL SWOT ANALYSIS
7.10. FRESENIUS KABI AG
7.10.1. INTRODUCTION
7.10.2. FRESENIUS KABI AGPRODUCT PORTFOLIO
7.10.3. FRESENIUS KABI AGRECENT ACTIVITIES
7.10.4. FRESENIUS KABI AGSWOT ANALYSIS
7.11. GREINER HOLDING AG
7.11.1. INTRODUCTION
7.11.2. GREINER HOLDING AG PRODUCT PORTFOLIO
7.11.3. GREINER HOLDING AG RECENT ACTIVITIES
7.11.4. GREINER HOLDING AG SWOT ANALYSIS
7.12. GRIFOLS INTERNATIONAL S.A
7.12.1. INTRODUCTION
7.12.2. GRIFOLS INTERNATIONAL S.APRODUCT PORTFOLIO
7.12.3. GRIFOLS INTERNATIONAL S.ARECENT ACTIVITIES
7.12.4. GRIFOLS INTERNATIONAL S.ASWOT ANALYSIS
7.13. HAEMONETICS CORPORATION
7.13.1. INTRODUCTION
7.13.2. HAEMONETICS CORPORATION PRODUCT PORTFOLIO
7.13.3. HAEMONETICS CORPORATION RECENT ACTIVITIES
7.13.4. HAEMONETICS CORPORATION SWOT ANALYSIS
7.14. IMMUCOR, INC.
7.14.1. INTRODUCTION
7.14.2. IMMUCOR, INC. PRODUCT PORTFOLIO
7.14.3. IMMUCOR, INC. RECENT ACTIVITIES
7.14.4. IMMUCOR, INC. SWOT ANALYSIS
7.15. JMS CO. LTD
7.15.1. INTRODUCTION
7.15.2. JMS CO. LTD PRODUCT PORTFOLIO
7.15.3. JMS CO. LTD RECENT ACTIVITIES
7.15.4. JMS CO. LTD SWOT ANALYSIS
7.16. MEDTRONIC
7.16.1. INTRODUCTION
7.16.2. MEDTRONIC PRODUCT PORTFOLIO
7.16.3. MEDTRONIC RECENT ACTIVITIES
7.16.4. MEDTRONIC SWOT ANALYSIS
7.17. NIPRO MEDICAL CORPORATION
7.17.1. INTRODUCTION
7.17.2. NIPRO MEDICAL CORPORATION PRODUCT PORTFOLIO
7.17.3. NIPRO MEDICAL CORPORATION RECENT ACTIVITIES
7.17.4. NIPRO MEDICAL CORPORATION SWOT ANALYSIS
7.18. QIAGEN
7.18.1. INTRODUCTION
7.18.2. QIAGEN PRODUCT PORTFOLIO
7.18.3. QIAGEN RECENT ACTIVITIES
7.18.4. QIAGEN SWOT ANALYSIS
7.19. SARSTEDT AG & CO.
7.19.1. INTRODUCTION
7.19.2. SARSTEDT AG & CO. PRODUCT PORTFOLIO
7.19.3. SARSTEDT AG & CO. RECENT ACTIVITIES
7.19.4. SARSTEDT AG & CO. SWOT ANALYSIS
7.20. TERUMO CORPORATION
7.20.1. INTRODUCTION
7.20.2. TERUMO CORPORATION PRODUCT PORTFOLIO
7.20.3. TERUMO CORPORATION RECENT ACTIVITIES
7.20.4. TERUMO CORPORATION SWOT ANALYSIS
FIGURE # 1 GLOBAL BLOOD COLLECTION MARKET BY GEOGRAPHY
FIGURE # 2 GLOBAL APPLICATION MARKET 2015 AND 2021
FIGURE # 3 GLOBAL BLOOD COLLECTION MARKET BY END USER 2015 AND 2021
FIGURE # 4 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 13 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 14 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 15 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES INC.
7.1.1. INTRODUCTION
7.1.2. ABBOTT LABORATORIES INC. PRODUCT PORTFOLIO
7.1.3. ABBOTT LABORATORIES INC. RECENT ACTIVITIES
7.1.4. ABBOTT LABORATORIES INC. SWOT ANALYSIS
7.2. ADVACARE PHARMACEUTICALS
7.2.1. INTRODUCTION
7.2.2. ADVACARE PHARMACEUTICALS PRODUCT PORTFOLIO
7.2.3. ADVACARE PHARMACEUTICALS RECENT ACTIVITIES
7.2.4. ADVACARE PHARMACEUTICALS SWOT ANALYSIS
7.3. ARGON
7.3.1. INTRODUCTION
7.3.2. ARGON PRODUCT PORTFOLIO
7.3.3. ARGON RECENT ACTIVITIES
7.3.4. ARGON SWOT ANALYSIS
7.4. BECKMAN COULTER, INC.
7.4.1. INTRODUCTION
7.4.2. BECKMAN COULTER, INC.PRODUCT PORTFOLIO
7.4.3. BECKMAN COULTER, INC.RECENT ACTIVITIES
7.4.4. BECKMAN COULTER, INC.SWOT ANALYSIS
7.5. BECTON DICKINSON AND COMPANY
7.5.1. INTRODUCTION
7.5.2. BECTON DICKINSON AND COMPANY PRODUCT PORTFOLIO
7.5.3. BECTON DICKINSON AND COMPANY RECENT ACTIVITIES
7.5.4. BECTON DICKINSON AND COMPANY SWOT ANALYSIS
7.6. COVIDIEN
7.6.1. INTRODUCTION
7.6.2. COVIDIEN PRODUCT PORTFOLIO
7.6.3. COVIDIEN RECENT ACTIVITIES
7.6.4. COVIDIEN SWOT ANALYSIS
7.7. CR BARD
7.7.1. INTRODUCTION
7.7.2. CR BARD PRODUCT PORTFOLIO
7.7.3. CR BARD RECENT ACTIVITIES
7.7.4. CR BARD SWOT ANALYSIS
7.8. ECOLAB
7.8.1. INTRODUCTION
7.8.2. ECOLAB PRODUCT PORTFOLIO
7.8.3. ECOLAB RECENT ACTIVITIES
7.8.4. ECOLAB SWOT ANALYSIS
7.9. FL MEDICAL
7.9.1. INTRODUCTION
7.9.2. FL MEDICAL PRODUCT PORTFOLIO
7.9.3. FL MEDICAL RECENT ACTIVITIES
7.9.4. FL MEDICAL SWOT ANALYSIS
7.10. FRESENIUS KABI AG
7.10.1. INTRODUCTION
7.10.2. FRESENIUS KABI AGPRODUCT PORTFOLIO
7.10.3. FRESENIUS KABI AGRECENT ACTIVITIES
7.10.4. FRESENIUS KABI AGSWOT ANALYSIS
7.11. GREINER HOLDING AG
7.11.1. INTRODUCTION
7.11.2. GREINER HOLDING AG PRODUCT PORTFOLIO
7.11.3. GREINER HOLDING AG RECENT ACTIVITIES
7.11.4. GREINER HOLDING AG SWOT ANALYSIS
7.12. GRIFOLS INTERNATIONAL S.A
7.12.1. INTRODUCTION
7.12.2. GRIFOLS INTERNATIONAL S.APRODUCT PORTFOLIO
7.12.3. GRIFOLS INTERNATIONAL S.ARECENT ACTIVITIES
7.12.4. GRIFOLS INTERNATIONAL S.ASWOT ANALYSIS
7.13. HAEMONETICS CORPORATION
7.13.1. INTRODUCTION
7.13.2. HAEMONETICS CORPORATION PRODUCT PORTFOLIO
7.13.3. HAEMONETICS CORPORATION RECENT ACTIVITIES
7.13.4. HAEMONETICS CORPORATION SWOT ANALYSIS
7.14. IMMUCOR, INC.
7.14.1. INTRODUCTION
7.14.2. IMMUCOR, INC. PRODUCT PORTFOLIO
7.14.3. IMMUCOR, INC. RECENT ACTIVITIES
7.14.4. IMMUCOR, INC. SWOT ANALYSIS
7.15. JMS CO. LTD
7.15.1. INTRODUCTION
7.15.2. JMS CO. LTD PRODUCT PORTFOLIO
7.15.3. JMS CO. LTD RECENT ACTIVITIES
7.15.4. JMS CO. LTD SWOT ANALYSIS
7.16. MEDTRONIC
7.16.1. INTRODUCTION
7.16.2. MEDTRONIC PRODUCT PORTFOLIO
7.16.3. MEDTRONIC RECENT ACTIVITIES
7.16.4. MEDTRONIC SWOT ANALYSIS
7.17. NIPRO MEDICAL CORPORATION
7.17.1. INTRODUCTION
7.17.2. NIPRO MEDICAL CORPORATION PRODUCT PORTFOLIO
7.17.3. NIPRO MEDICAL CORPORATION RECENT ACTIVITIES
7.17.4. NIPRO MEDICAL CORPORATION SWOT ANALYSIS
7.18. QIAGEN
7.18.1. INTRODUCTION
7.18.2. QIAGEN PRODUCT PORTFOLIO
7.18.3. QIAGEN RECENT ACTIVITIES
7.18.4. QIAGEN SWOT ANALYSIS
7.19. SARSTEDT AG & CO.
7.19.1. INTRODUCTION
7.19.2. SARSTEDT AG & CO. PRODUCT PORTFOLIO
7.19.3. SARSTEDT AG & CO. RECENT ACTIVITIES
7.19.4. SARSTEDT AG & CO. SWOT ANALYSIS
7.20. TERUMO CORPORATION
7.20.1. INTRODUCTION
7.20.2. TERUMO CORPORATION PRODUCT PORTFOLIO
7.20.3. TERUMO CORPORATION RECENT ACTIVITIES
7.20.4. TERUMO CORPORATION SWOT ANALYSIS
